OpenVSafe by OpenVAERS
Search V-safe

6M5-23431-49932

2 vaccinations 3 coded responses 8 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
086 / NJ
Registered
2021-03-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-16
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-09
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-12
    Registered in v-safe
  4. 2021-03-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-03-17
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-03-31
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  7. 2021-04-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-04-15
    Survey response — day 35, dose 2
    MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Premenstrual syndrome — Feeling: Good
    Free text: Stronger premenstrual symptoms for 1 1/2 weeks prior, strong cramps for inital start of period and heavy flow in the beginning. It calmed down by mid day on first day
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-06-10
    Survey response — 3 months, dose 2
    MedDRA: Menstruation delayed — Feeling: Good
    Free text: Still no period or premenstrual symptoms. Started having issues in April exactly one month after receiving 2nd dose in March. Having testing done to see if there is another health issue causing this.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-09-07
    Survey response — 6 months, dose 2
    MedDRA: Menstruation irregular — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Skipped period for one month after vaccine
    MedDRA releases: 2024-11 · check-in free text available
  12. 2021-09-07
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-09-13

Vaccinations

DoseDateManufacturerCo-administered
12021-02-16Pfizer-BioNTech
22021-03-09Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 7 — day 35, dose 2

2021-04-15

Symptoms: Stronger premenstrual symptoms for 1 1/2 weeks prior, strong cramps for inital start of period and heavy flow in the beginning. It calmed down by mid day on first day

Release 9 — 3 months, dose 2

2021-06-10

Symptoms: Still no period or premenstrual symptoms. Started having issues in April exactly one month after receiving 2nd dose in March. Having testing done to see if there is another health issue causing this.

Release 9 — 6 months, dose 2

2021-09-07

Symptoms: Skipped period for one month after vaccine

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDysmenorrhoea ✓ ✓ ✓
SDHeavy menstrual bleeding ✓ ✓ ✓
SDMenstruation delayed ✓ ✓ ✓
SDMenstruation irregular · · ✓
SDPremenstrual syndrome ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release